Barrow WW - Search Results

1

The metabolism of 2-methyladenosine in Mycobacterium smegmatis.

Chen CK, Barrow EW, Allan PW, Bansal N, Maddry JA, Suling WJ, Barrow WW, Parker WB. Chen CK, et al. Among authors: barrow ew, barrow ww. Microbiology (Reading). 2002 Jan;148(Pt 1):289-295. doi: 10.1099/00221287-148-1-289. Microbiology (Reading). 2002. PMID: 11782521 Free article.

2

Metabolism of 2-methyladenosine in Mycobacterium tuberculosis.

Parker WB, Barrow EW, Allan PW, Shaddix SC, Long MC, Barrow WW, Bansal N, Maddry JA. Parker WB, et al. Among authors: barrow ew, barrow ww. Tuberculosis (Edinb). 2004;84(5):327-36. doi: 10.1016/j.tube.2004.02.004. Tuberculosis (Edinb). 2004. PMID: 15207808

3

Antimycobacterial activity of 2-methyl-adenosine.

Barrow EW, Westbrook L, Bansal N, Suling WJ, Maddry JA, Parker WB, Barrow WW. Barrow EW, et al. Among authors: barrow ww. J Antimicrob Chemother. 2003 Nov;52(5):801-8. doi: 10.1093/jac/dkg444. Epub 2003 Oct 16. J Antimicrob Chemother. 2003. PMID: 14563890

4

Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase.

Suling WJ, Reynolds RC, Barrow EW, Wilson LN, Piper JR, Barrow WW. Suling WJ, et al. Among authors: barrow ew, barrow ww. J Antimicrob Chemother. 1998 Dec;42(6):811-5. doi: 10.1093/jac/42.6.811. J Antimicrob Chemother. 1998. PMID: 10052907

5

New Mycobacterium avium antifolate shows synergistic effect when used in combination with dihydropteroate synthase inhibitors.

Suling WJ, Seitz LE, Reynolds RC, Barrow WW. Suling WJ, et al. Among authors: barrow ww. Antimicrob Agents Chemother. 2005 Nov;49(11):4801-3. doi: 10.1128/AAC.49.11.4801-4803.2005. Antimicrob Agents Chemother. 2005. PMID: 16251337 Free PMC article.

6

Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies.

Wright EL, Quenelle DC, Suling WJ, Barrow WW. Wright EL, et al. Among authors: barrow ww. Antimicrob Agents Chemother. 1996 Sep;40(9):2206-8. doi: 10.1128/AAC.40.9.2206. Antimicrob Agents Chemother. 1996. PMID: 8878609 Free PMC article.

7

Identification and cloning of the Mycobacterium avium folA gene, required for dihydrofolate reductase activity.

Zywno-van Ginkel S, Dooley TP, Suling WJ, Barrow WW. Zywno-van Ginkel S, et al. Among authors: barrow ww. FEMS Microbiol Lett. 1997 Nov 1;156(1):69-78. doi: 10.1111/j.1574-6968.1997.tb12707.x. FEMS Microbiol Lett. 1997. PMID: 9368362

8

Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase.

Suling WJ, Seitz LE, Pathak V, Westbrook L, Barrow EW, Zywno-Van-Ginkel S, Reynolds RC, Piper JR, Barrow WW. Suling WJ, et al. Among authors: barrow ew, barrow ww. Antimicrob Agents Chemother. 2000 Oct;44(10):2784-93. doi: 10.1128/AAC.44.10.2784-2793.2000. Antimicrob Agents Chemother. 2000. PMID: 10991861 Free PMC article.

9

Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.

Xu ZQ, Barrow WW, Suling WJ, Westbrook L, Barrow E, Lin YM, Flavin MT. Xu ZQ, et al. Among authors: barrow e, barrow ww. Bioorg Med Chem. 2004 Mar 1;12(5):1199-207. doi: 10.1016/j.bmc.2003.11.012. Bioorg Med Chem. 2004. PMID: 14980631

10

New antifolate inhibitors for Mycobacterium avium.

Barrow EW, Suling WJ, Seitz LE, Reynolds RC, Barrow WW. Barrow EW, et al. Among authors: barrow ww. Med Chem. 2006 Sep;2(5):505-10. doi: 10.2174/157340606778250225. Med Chem. 2006. PMID: 17017990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page